Article Details

Seres Therapeutics (MCRB) Rating Increased to Hold at ValuEngine

Retrieved on: 2018-06-09 18:52:30

Tags for this article:

Click the tags to see associated articles and topics

Seres Therapeutics (MCRB) Rating Increased to Hold at ValuEngine. View article details on hiswai:

Excerpt

<div>Finally, <b>Two Sigma Investments</b> LP increased its stake in Seres Therapeutics by 243.3% during the 4th quarter. <b>Two Sigma Investments</b> LP now owns ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up